81 related articles for article (PubMed ID: 28012015)
21. Modulation of the vitamin D3 response by cancer-associated mutant p53.
Stambolsky P; Tabach Y; Fontemaggi G; Weisz L; Maor-Aloni R; Siegfried Z; Shiff I; Kogan I; Shay M; Kalo E; Blandino G; Simon I; Oren M; Rotter V
Cancer Cell; 2010 Mar; 17(3):273-85. PubMed ID: 20227041
[TBL] [Abstract][Full Text] [Related]
22. Colon cancer: preventive agents and the present status of chemoprevention.
Half E; Arber N
Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
[TBL] [Abstract][Full Text] [Related]
23. Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene.
Lo HW; Stephenson L; Cao X; Milas M; Pollock R; Ali-Osman F
Mol Cancer Res; 2008 May; 6(5):843-50. PubMed ID: 18505928
[TBL] [Abstract][Full Text] [Related]
24. Shaping genetic alterations in human cancer: the p53 mutation paradigm.
Soussi T; Wiman KG
Cancer Cell; 2007 Oct; 12(4):303-12. PubMed ID: 17936556
[TBL] [Abstract][Full Text] [Related]
25. Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria.
Zimmermann AK; Loucks FA; Schroeder EK; Bouchard RJ; Tyler KL; Linseman DA
J Biol Chem; 2007 Oct; 282(40):29296-304. PubMed ID: 17690097
[TBL] [Abstract][Full Text] [Related]
26. The oncogenic roles of p53 mutants in mouse models.
Lozano G
Curr Opin Genet Dev; 2007 Feb; 17(1):66-70. PubMed ID: 17208429
[TBL] [Abstract][Full Text] [Related]
27. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
28. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.
Trachootham D; Zhou Y; Zhang H; Demizu Y; Chen Z; Pelicano H; Chiao PJ; Achanta G; Arlinghaus RB; Liu J; Huang P
Cancer Cell; 2006 Sep; 10(3):241-52. PubMed ID: 16959615
[TBL] [Abstract][Full Text] [Related]
29. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.
Kume S; Haneda M; Kanasaki K; Sugimoto T; Araki S; Isono M; Isshiki K; Uzu T; Kashiwagi A; Koya D
Free Radic Biol Med; 2006 Jun; 40(12):2175-82. PubMed ID: 16785031
[TBL] [Abstract][Full Text] [Related]
30. p53 regulates mitochondrial respiration.
Matoba S; Kang JG; Patino WD; Wragg A; Boehm M; Gavrilova O; Hurley PJ; Bunz F; Hwang PM
Science; 2006 Jun; 312(5780):1650-3. PubMed ID: 16728594
[TBL] [Abstract][Full Text] [Related]
31. Drug approval triggers debate on future direction for cancer treatments.
Frantz S
Nat Rev Drug Discov; 2006 Feb; 5(2):91. PubMed ID: 16521324
[No Abstract] [Full Text] [Related]
32. Targeting multidrug resistance in cancer.
Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 defends the lung from oxidative stress.
Cho HY; Reddy SP; Kleeberger SR
Antioxid Redox Signal; 2006; 8(1-2):76-87. PubMed ID: 16487040
[TBL] [Abstract][Full Text] [Related]
34. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
35. Drug discovery: playing dirty.
Frantz S
Nature; 2005 Oct; 437(7061):942-3. PubMed ID: 16222266
[No Abstract] [Full Text] [Related]
36. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
Morales MC; Pérez-Yarza G; Nieto-Rementeria N; Boyano MD; Jangi M; Atencia R; Asumendi A
Anticancer Res; 2005; 25(3B):1945-51. PubMed ID: 16158929
[TBL] [Abstract][Full Text] [Related]
37. Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells.
Behrend L; Mohr A; Dick T; Zwacka RM
Mol Cell Biol; 2005 Sep; 25(17):7758-69. PubMed ID: 16107721
[TBL] [Abstract][Full Text] [Related]
38. [WITHDRAWN] Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype.
Thiruchelvam M; Prokopenko O; Cory-Slechta DA; Richfield EK; Buckley B; Mirochnitchenko O
J Biol Chem; 2005 Jun; 280(23):22530-9. PubMed ID: 15824117
[TBL] [Abstract][Full Text] [Related]
39. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
Kang YH; Yi MJ; Kim MJ; Park MT; Bae S; Kang CM; Cho CK; Park IC; Park MJ; Rhee CH; Hong SI; Chung HY; Lee YS; Lee SJ
Cancer Res; 2004 Dec; 64(24):8960-7. PubMed ID: 15604259
[TBL] [Abstract][Full Text] [Related]
40. The pathophysiology of mitochondrial cell death.
Green DR; Kroemer G
Science; 2004 Jul; 305(5684):626-9. PubMed ID: 15286356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
